Document Detail


Early prediction of sepsis-induced disseminated intravascular coagulation with interleukin-10, interleukin-6, and RANTES in preterm infants.
MedLine Citation:
PMID:  16613997     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The progression to disseminated intravascular coagulation (DIC) in infected very low birth weight (VLBW; <1500 g) infants is difficult to predict with precision at the onset of sepsis. We investigated the immunologic profiles of preterm infants with sepsis, using chemokine and cytokine measurements to predict the development of sepsis-induced DIC at the onset of infection. METHODS: We measured a panel of chemokines and cytokines at 0 and 24 h after clinical presentation in VLBW infants with suspected infection requiring full sepsis screening. The chemokines measured were interleukin (IL)-8, interferon-gamma-inducible protein-10 (IP-10), monokine induced by interferon-gamma, monocyte chemoattractant protein-1, and regulated upon activation normal T-cell expressed and secreted (RANTES), and the cytokines were IL-6, IL-10, and tumor necrosis factor-alpha. RESULTS: Of 195 episodes of suspected clinical sepsis investigated, 62 were culture-confirmed septicemia or necrotizing enterocolitis (28 of these infants developed DIC), 22 were culture-negative clinical infections, and 111 involved noninfected episodes. All studied inflammatory mediators except RANTES showed significantly greater up-regulation in culture-positive infected infants than in noninfected infants at 0 and 24 h, whereas RANTES showed significant down-regulation. The model that used plasma IL-10 (>208 ng/L), IL-6 (>168 ng/L), and RANTES (<3110 ng/L) at 0 h had sensitivity, specificity, and positive and negative predictive values of 100%, 97%, 85%, and 100%, respectively, for identifying infected patients who subsequently developed DIC. CONCLUSIONS: IL-10, IL-6, and RANTES measured at clinical presentation sensitively and accurately predicted the development of DIC in severely infected infants. This information could be vital for early and effective treatment of neonatal sepsis.
Authors:
Pak C Ng; Karen Li; Ting F Leung; Raymond P O Wong; Geng Li; Kit M Chui; Eric Wong; Frankie W T Cheng; Tai F Fok
Related Documents :
20930597 - Multiple ecthyma gangrenosum in a healthy infant with community-acquired pseudomonas ae...
21448197 - Very low birth weight infants qualifying for a 'late' erythrocyte transfusion: does giv...
8071757 - Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclamp...
9574687 - Nonperinatal nosocomial transmission of candida albicans in a neonatal intensive care u...
24450427 - A follow-up study of lympho-histiocytic villitis and of incidental retroplacental hemat...
24888827 - Predictors of early lung function in patients with congenital diaphragmatic hernia.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2006-04-13
Journal Detail:
Title:  Clinical chemistry     Volume:  52     ISSN:  0009-9147     ISO Abbreviation:  Clin. Chem.     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-25     Completed Date:  2006-06-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9421549     Medline TA:  Clin Chem     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1181-9     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Center of Epidemiology and Biostatistics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region. pakcheungng@cuhk.edu.hk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chemokine CCL5 / blood*
Disseminated Intravascular Coagulation / diagnosis*,  etiology,  immunology
Down-Regulation
Enterocolitis, Necrotizing / blood,  complications
Humans
Infant, Low Birth Weight
Infant, Newborn
Infant, Premature*
Interleukin-10 / blood*
Interleukin-6 / blood*
Predictive Value of Tests
Prospective Studies
Sepsis / blood,  complications*
Up-Regulation
Chemical
Reg. No./Substance:
0/Chemokine CCL5; 0/Interleukin-6; 130068-27-8/Interleukin-10

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Feasibility of standardization of serum C-peptide immunoassays with isotope-dilution liquid chromato...
Next Document:  Effect of vitamin B12 treatment on haptocorrin.